Pensa Lucila A, Solernó Martín R, Rausch Silvia, Aruj Patricia K, Grinberg Alejandro R
Servicio de Clínica Médica, Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina. E-mail:
Servicio de Clínica Médica, Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina.
Medicina (B Aires). 2021;81(2):301-303.
Pulmonary alveolar proteinosis (PAP) is a rare, diffuse pulmonary disease due to abnormal surfactant homeostasis. We present the case of a 69-year-old woman who was admitted to the hospital for progressive dyspnea with marked limitation in activity, and non-productive cough, of three months of evolution. Type I respiratory failure was confirmed. Chest tomography findings were interlobular and intralobular septal thickening, ground glass opacities and bilateral consolidation. Histological diagnosis was made and whole-lung lavage was performed with clinical improvement. We highlight the need to keep in mind differential diagnoses of respiratory failure and pulmonary infiltrates during COVID-19 pandemic, even rare entities such as PAP.
肺泡蛋白沉积症(PAP)是一种由于表面活性物质稳态异常导致的罕见弥漫性肺部疾病。我们报告了一例69岁女性患者,因进行性呼吸困难、活动严重受限及干咳3个月入院。确诊为I型呼吸衰竭。胸部断层扫描结果显示小叶间和小叶内间隔增厚、磨玻璃影及双侧实变。进行了组织学诊断并实施了全肺灌洗,患者临床症状改善。我们强调,在新冠疫情期间,即使是像PAP这样的罕见疾病,也需要牢记呼吸衰竭和肺部浸润的鉴别诊断。